@madamswer, with respect, best stick to what you are truly expert at, namely investing.
Your post is a total misguide and you should ask to have it deleted.
"That's essentially what MSB's heart program is all about too" is utterly incorrect. If you don't know the difference between heart attacks and heart failure you shouldn't be posting on it.
I believe that MSB has expressed interest in what MPCs can do for myocardial infarcts but the two current advanced trials are testing for efficacy in remodelling failing hearts. If CSL can prevent secondary heart attacks, good on 'em but the only relevance to MSB is (a) great, CSL favours stem cells and is betting big bucks and (b) if CSL proves their stem cells can do it then quite possibly MSB's could also.
Madamswer's posts are usually well worth paying attention to. The above isn't one of them.
Interesting..., page-6
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.58 |
Change
0.005(0.32%) |
Mkt cap ! $1.798B | |||
| Open | High | Low | Value | Volume |
| $1.56 | $1.61 | $1.52 | $6.446M | 4.092M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 62215 | $1.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.58 | 14678 | 2 |
View Market Depth
| Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |